A Study to Evaluate the Effect of Food on the Bioavailability of AJ201, and Safety, Tolerability, and Pharmacokinetics of AJ201 in Japanese and White Healthy Male Participants
A Phase 1, Randomized, Single-dose, Open-label, Two-way, Crossover Study to Evaluate the Effect of Food on AJ201, and to Evaluate the Safety, Tolerability, and Pharmacokinetics of AJ201 in Japanese and White Healthy Male Participants
Sponsor: AnnJi Pharmaceutical Co., Ltd.
Listed as NCT07549919, this observational or N/A phase trial focuses on Food Effect in Healthy Volunteers and Healthy Male Adults and remains actively recruiting participants. Sponsored by AnnJi Pharmaceutical Co., Ltd., it has been updated 1 time since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recordedEligibility Summary
This is a Phase 1, randomized, single-dose, open-label, two-way crossover study to evaluate the effect of food on AJ201, and to evaluate the safety, tolerability, and pharmacokinetics of AJ201 in Japanese and White healthy male participants.
Contact Information
- AnnJi Pharmaceutical Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .